These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
740 related articles for article (PubMed ID: 14599348)
1. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP). Vainshtein I; Silveria S; Kaul P; Rouhani R; Eglen RM; Wang J J Biomol Screen; 2002 Dec; 7(6):507-14. PubMed ID: 14599348 [TBL] [Abstract][Full Text] [Related]
2. A homogeneous enzyme fragment complementation cyclic AMP screen for GPCR agonists. Golla R; Seethala R J Biomol Screen; 2002 Dec; 7(6):515-25. PubMed ID: 14599349 [TBL] [Abstract][Full Text] [Related]
3. A fluorescence lifetime based binding assay to characterize kinase inhibitors. Lebakken CS; Hee Chol Kang ; Vogel KW J Biomol Screen; 2007 Sep; 12(6):828-41. PubMed ID: 17644772 [TBL] [Abstract][Full Text] [Related]
4. A versatile high-throughput screen for inhibitors of lipid kinase activity: development of an immobilized phospholipid plate assay for phosphoinositide 3-kinase gamma. Fuchikami K; Togame H; Sagara A; Satoh T; Gantner F; Bacon KB; Reinemer P J Biomol Screen; 2002 Oct; 7(5):441-50. PubMed ID: 14599360 [TBL] [Abstract][Full Text] [Related]
5. Development of a fluorescence polarization bead-based coupled assay to target different activity/conformation states of a protein kinase. Lu Z; Yin Z; James L; Syto R; Stafford JM; Koseoglu S; Mayhood T; Myers J; Windsor W; Kirschmeier P; Samatar AA; Malcolm B; Turek-Etienne TC; Kumar CC J Biomol Screen; 2004 Jun; 9(4):309-21. PubMed ID: 15191648 [TBL] [Abstract][Full Text] [Related]
6. Cell-based high-throughput screening assay system for monitoring G protein-coupled receptor activation using beta-galactosidase enzyme complementation technology. Yan YX; Boldt-Houle DM; Tillotson BP; Gee MA; D'Eon BJ; Chang XJ; Olesen CE; Palmer MA J Biomol Screen; 2002 Oct; 7(5):451-9. PubMed ID: 14599361 [TBL] [Abstract][Full Text] [Related]
7. Homogeneous and nonradioactive high-throughput screening platform for the characterization of kinase inhibitors in cell lysates. Guenat S; Rouleau N; Bielmann C; Bedard J; Maurer F; Allaman-Pillet N; Nicod P; Bielefeld-Sévigny M; Beckmann JS; Bonny C; Bossé R; Roduit R J Biomol Screen; 2006 Dec; 11(8):1015-26. PubMed ID: 17092917 [TBL] [Abstract][Full Text] [Related]
9. Staurosporine-based binding assay for testing the affinity of compounds to protein kinases. Iyer GH; Taslimi P; Pazhanisamy S Anal Biochem; 2008 Feb; 373(2):197-206. PubMed ID: 18047825 [TBL] [Abstract][Full Text] [Related]
10. Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors. Simard JR; Getlik M; Grütter C; Pawar V; Wulfert S; Rabiller M; Rauh D J Am Chem Soc; 2009 Sep; 131(37):13286-96. PubMed ID: 19572644 [TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R. Traxler P; Furet P; Mett H; Buchdunger E; Meyer T; Lydon N J Pharm Belg; 1997; 52(2):88-96. PubMed ID: 9193132 [TBL] [Abstract][Full Text] [Related]
12. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures. Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178 [TBL] [Abstract][Full Text] [Related]
13. Three mechanistically distinct kinase assays compared: Measurement of intrinsic ATPase activity identified the most comprehensive set of ITK inhibitors. Kashem MA; Nelson RM; Yingling JD; Pullen SS; Prokopowicz AS; Jones JW; Wolak JP; Rogers GR; Morelock MM; Snow RJ; Homon CA; Jakes S J Biomol Screen; 2007 Feb; 12(1):70-83. PubMed ID: 17166826 [TBL] [Abstract][Full Text] [Related]
14. Real-time protein kinase assay. Sun H; Low KE; Woo S; Noble RL; Graham RJ; Connaughton SS; Gee MA; Lee LG Anal Chem; 2005 Apr; 77(7):2043-9. PubMed ID: 15801736 [TBL] [Abstract][Full Text] [Related]
15. Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform. Lebakken CS; Riddle SM; Singh U; Frazee WJ; Eliason HC; Gao Y; Reichling LJ; Marks BD; Vogel KW J Biomol Screen; 2009 Sep; 14(8):924-35. PubMed ID: 19564447 [TBL] [Abstract][Full Text] [Related]
16. Fluorescence labels in kinases: a high-throughput kinase binding assay for the identification of DFG-out binding ligands. Simard JR; Rauh D Methods Mol Biol; 2012; 800():95-117. PubMed ID: 21964785 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of a competitive AKT serine/threonine kinase fluorescence polarization assay using a product-specific anti-phospho-serine antibody. Turek TC; Small EC; Bryant RW; Hill WA Anal Biochem; 2001 Dec; 299(1):45-53. PubMed ID: 11726183 [TBL] [Abstract][Full Text] [Related]
18. Proteome-wide discovery of unknown ATP-binding proteins and kinase inhibitor target proteins using an ATP probe. Adachi J; Kishida M; Watanabe S; Hashimoto Y; Fukamizu K; Tomonaga T J Proteome Res; 2014 Dec; 13(12):5461-70. PubMed ID: 25230287 [TBL] [Abstract][Full Text] [Related]
19. A liquid chromatography/mass spectrometry-based method for the selection of ATP competitive kinase inhibitors. Khandekar SS; Feng B; Yi T; Chen S; Laping N; Bramson N J Biomol Screen; 2005 Aug; 10(5):447-55. PubMed ID: 16093554 [TBL] [Abstract][Full Text] [Related]
20. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry. Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]